Harry Simeonidis

CIK 1831767 · Chief Executive Officer · last filed 2026-03-20

Harry Simeonidis is a Chief Executive Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for INBS, was dated Mar 20, 2026. Across all open-market trades the lifetime net is +$284, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $82.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$82.9K

Companies

2

Total Filings

4

Lifetime Open-Market Net

$284

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INBS Chief Executive Officer 34,540 $2.40 $82.9K $284 3 2026-03-20
INTELLIGENT BIO SOLUTIONS INC. (GBS) Delisted President 80,600 $0.47 $38.1K $0 1 2022-10-12

Recent Filings

4 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-20 INBS Grant (A) +30,500 $0 EDGAR
2024-09-27 INBS Grant (A) +40,000 $0 EDGAR
2023-09-05 INBS Buy (P) +150 $284 EDGAR
2022-10-12 INTELLIGENT BIO SOLUTIONS INC. (GBS) Delisted Grant (A) +80,000 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.